Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannoid is a private Colorado-based contract developer and manufacturer focused on cannabinoid-based products, especially softgel encapsulation of CBD and related hemp-derived oils. Founded in 2013, the company positions itself as a development and manufacturing engine for brands in the hemp and CBD sector, offering formulation, analytical, quality, and production capabilities. Its services and products include bulk and custom cannabinoid softgels, tinctures, topicals, and raw hemp-derived ingredients. Cannoid also states that it supports physician- or caregiver-referred consumer distribution through its affiliated brand Entourage Hemp. The company appears to operate commercially rather than as a clinical-stage drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannoid.